BCAX
Bicara Therapeutics Inc.Company with tickers: BCAX
CIK
2023658
CUSIP
055477103
Shares Outstanding
65,703,866
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-18 | Mazumdar Claire | Director, Chief Executive Officer | Sell | 12,022 |
| 2026-05-18 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 15,000 |
| 2026-05-18 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 15,000 |
| 2026-05-18 | Mazumdar Claire | Director, Chief Executive Officer | Sell | 2,978 |
| 2026-05-15 | Cohlhepp Ryan | Director, President and COO | Sell | 8,000 |
| 2026-05-15 | Cohlhepp Ryan | Director, President and COO | Convert | 8,000 |
| 2026-05-15 | Cohlhepp Ryan | Director, President and COO | Convert | 8,000 |
| 2026-05-15 | Cohlhepp Ryan | Director, President and COO | Sell | 4,500 |
| 2026-05-08 | Schelman William | Chief Medical Officer | Award | 85,000 |
| 2026-05-08 | Schelman William | Chief Medical Officer | Other | 0 |
| 2026-05-08 | Schelman William | Chief Medical Officer | Other | 0 |
| 2026-04-27 | Raben David | Chief Medical Officer | Sell | 5,500 |
| 2026-04-27 | Raben David | Chief Medical Officer | Convert | 5,500 |
| 2026-04-27 | Raben David | Chief Medical Officer | Convert | 5,500 |
| 2026-04-21 | Hyep Ivan | Chief Financial Officer | Convert | 9,200 |
| 2026-04-21 | Hyep Ivan | Chief Financial Officer | Sell | 9,200 |
| 2026-04-21 | Hyep Ivan | Chief Financial Officer | Convert | 9,200 |
| 2026-04-20 | Mazumdar Claire | Director, Chief Executive Officer | Sell | 15,000 |
| 2026-04-20 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 15,000 |
| 2026-04-20 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 15,000 |
| 2026-04-16 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 7,080 |
| 2026-04-16 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 8,226 |
| 2026-04-16 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 8,226 |
| 2026-04-16 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 7,454 |
| 2026-04-16 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 7,454 |
| 2026-04-16 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 7,080 |
| 2026-04-15 | Cohlhepp Ryan | Director, President and COO | Sell | 8,000 |
| 2026-04-15 | Cohlhepp Ryan | Director, President and COO | Convert | 8,000 |
| 2026-04-15 | Cohlhepp Ryan | Director, President and COO | Sell | 4,500 |
| 2026-04-15 | Cohlhepp Ryan | Director, President and COO | Convert | 8,000 |
| 2026-03-25 | Raben David | Chief Medical Officer | Convert | 5,500 |
| 2026-03-25 | Raben David | Chief Medical Officer | Sell | 5,500 |
| 2026-03-25 | Raben David | Chief Medical Officer | Convert | 5,500 |
| 2026-03-23 | Hyep Ivan | Chief Financial Officer | Sell | 9,200 |
| 2026-03-23 | Hyep Ivan | Chief Financial Officer | Convert | 9,200 |
| 2026-03-23 | Hyep Ivan | Chief Financial Officer | Convert | 9,200 |
| 2026-03-20 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 1,596 |
| 2026-03-20 | Mazumdar Claire | Director, Chief Executive Officer | Sell | 1,596 |
| 2026-03-20 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 1,596 |
| 2026-03-19 | Mazumdar Claire | Director, Chief Executive Officer | Sell | 6,905 |
| 2026-03-19 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 6,905 |
| 2026-03-19 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 6,905 |
| 2026-03-18 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 6,499 |
| 2026-03-18 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 6,499 |
| 2026-03-18 | Mazumdar Claire | Director, Chief Executive Officer | Sell | 6,499 |
| 2026-03-16 | Cohlhepp Ryan | Director, President and COO | Sell | 8,000 |
| 2026-03-16 | Cohlhepp Ryan | Director, President and COO | Convert | 8,000 |
| 2026-03-16 | Cohlhepp Ryan | Director, President and COO | Sell | 4,500 |
| 2026-03-16 | Cohlhepp Ryan | Director, President and COO | Convert | 8,000 |
| 2026-03-09 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 36,766 |
| 2026-03-09 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 36,766 |
| 2026-03-09 | Mazumdar Claire | Director, Chief Executive Officer | Sell | 36,766 |
| 2026-03-06 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 3,817 |
| 2026-03-06 | Mazumdar Claire | Director, Chief Executive Officer | Sell | 3,817 |
| 2026-03-06 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 3,817 |
| 2026-03-05 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 1,786 |
| 2026-03-05 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 1,786 |
| 2026-03-05 | Mazumdar Claire | Director, Chief Executive Officer | Sell | 1,786 |
| 2026-03-04 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 2,631 |
| 2026-03-04 | Mazumdar Claire | Director, Chief Executive Officer | Sell | 2,631 |
| 2026-03-04 | Mazumdar Claire | Director, Chief Executive Officer | Convert | 2,631 |
| 2026-03-04 | Hyep Ivan | Chief Financial Officer | Convert | 2,963 |
| 2026-03-04 | Hyep Ivan | Chief Financial Officer | Sell | 2,963 |
| 2026-03-04 | Hyep Ivan | Chief Financial Officer | Convert | 2,963 |
| 2026-03-04 | Raben David | Chief Medical Officer | Sell | 16,300 |
| 2026-03-04 | Raben David | Chief Medical Officer | Convert | 16,300 |
| 2026-03-04 | Raben David | Chief Medical Officer | Convert | 16,300 |
| 2026-03-03 | Hyep Ivan | Chief Financial Officer | Convert | 6,237 |
| 2026-03-03 | Hyep Ivan | Chief Financial Officer | Convert | 7,318 |
| 2026-03-03 | Hyep Ivan | Chief Financial Officer | Convert | 7,318 |
| 2026-03-03 | Hyep Ivan | Chief Financial Officer | Convert | 6,237 |
| 2026-03-03 | Hyep Ivan | Chief Financial Officer | Sell | 13,555 |
| 2026-03-03 | Raben David | Chief Medical Officer | Convert | 200 |
| 2026-03-03 | Raben David | Chief Medical Officer | Sell | 200 |
| 2026-03-03 | Raben David | Chief Medical Officer | Convert | 200 |
| 2026-03-03 | Cohlhepp Ryan | Director, President and COO | Sell | 4,500 |
| 2026-03-03 | Cohlhepp Ryan | Director, President and COO | Convert | 12,892 |
| 2026-03-03 | Cohlhepp Ryan | Director, President and COO | Sell | 12,892 |
| 2026-03-03 | Cohlhepp Ryan | Director, President and COO | Convert | 12,892 |
| 2026-02-26 | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 2,200,000 |
| 2026-02-26 | RA CAPITAL MANAGEMENT, L.P. | Director | Buy | 300,000 |
| 2026-02-26 | RA CAPITAL MANAGEMENT, L.P. | Director | Other | 2,652,575 |
| 2026-02-25 | Cohlhepp Ryan | Director, President and COO | Convert | 3,108 |
| 2026-02-25 | Cohlhepp Ryan | Director, President and COO | Sell | 523 |
| 2026-02-25 | Cohlhepp Ryan | Director, President and COO | Sell | 3,108 |
| 2026-02-25 | Cohlhepp Ryan | Director, President and COO | Convert | 3,108 |
| 2026-02-02 | Raben David | Chief Medical Officer | Award | 100,000 |
| 2026-02-02 | Hyep Ivan | Chief Financial Officer | Award | 125,000 |
| 2026-02-02 | Mazumdar Claire | Director, Chief Executive Officer | Award | 450,000 |
| 2026-02-02 | Cohlhepp Ryan | Director, President and COO | Award | 300,000 |
| 2026-02-02 | Meisner Lara | Chief Legal Officer | Award | 90,000 |
| 2026-01-22 | Cohlhepp Ryan | Director, President and COO | Sell | 3,828 |
| 2026-01-22 | Hyep Ivan | Chief Financial Officer | Convert | 1,882 |
| 2026-01-22 | Hyep Ivan | Chief Financial Officer | Convert | 1,882 |
| 2026-01-22 | Hyep Ivan | Chief Financial Officer | Sell | 1,882 |
| 2026-01-15 | Cohlhepp Ryan | Director, President and COO | Sell | 149 |
| 2025-12-26 | Cohlhepp Ryan | Director, President and COO | Convert | 25,000 |
| 2025-12-26 | Cohlhepp Ryan | Director, President and COO | Convert | 25,000 |
| 2025-12-26 | Raben David | Chief Medical Officer | Convert | 19,789 |
| 2025-12-26 | Raben David | Chief Medical Officer | Convert | 19,789 |